Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | cytochrome P450, family 2, subfamily D, polypeptide 6 | References | |
Homo sapiens | cytochrome P450, family 1, subfamily A, polypeptide 2 | References | |
Homo sapiens | cytochrome P450, family 3, subfamily A, polypeptide 4 | References |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Brugia malayi | Cytochrome P450 family protein | cytochrome P450, family 1, subfamily A, polypeptide 2 | 516 aa | 470 aa | 26.2 % |
Brugia malayi | cytochrome P450 | cytochrome P450, family 2, subfamily D, polypeptide 6 | 497 aa | 425 aa | 32.0 % |
Brugia malayi | cytochrome P450 | cytochrome P450, family 3, subfamily A, polypeptide 4 | 502 aa | 492 aa | 24.2 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trypanosoma cruzi | cytochrome P450, putative | 0.0023 | 0.5 | 0.5 |
Mycobacterium ulcerans | cytochrome P450 185A4 Cyp185A4 | 0.0023 | 0.5 | 0.5 |
Loa Loa (eye worm) | CYP4Cod1 | 0.0023 | 0.5 | 0.5 |
Loa Loa (eye worm) | cytochrome P450 family protein | 0.0023 | 0.5 | 0.5 |
Brugia malayi | Cytochrome P450 family protein | 0.0023 | 0.5 | 0.5 |
Loa Loa (eye worm) | cytochrome P450 family protein | 0.0023 | 0.5 | 0.5 |
Leishmania major | cytochrome p450-like protein | 0.0023 | 0.5 | 0.5 |
Trypanosoma cruzi | cytochrome P450, putative | 0.0023 | 0.5 | 0.5 |
Trypanosoma brucei | cytochrome P450, putative | 0.0023 | 0.5 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
AUC (ADMET) | AUC100 in po dosed mouse | ChEMBL. | 26643218 | |
CL (ADMET) | Clearance in iv dosed mouse | ChEMBL. | 26643218 | |
F (ADMET) | Oral bioavailability in mouse | ChEMBL. | 26643218 | |
IC50 (ADMET) | Inhibition of human recombinant CYP2C9 by fluorescence assay | ChEMBL. | 26643218 | |
IC50 (ADMET) | = 5.24 uM | Inhibition of human recombinant CYP2D6 by fluorescence assay | ChEMBL. | 26643218 |
IC50 (ADMET) | = 17.9 uM | Inhibition of human recombinant CYP1A2 by fluorescence assay | ChEMBL. | 26643218 |
IC50 (ADMET) | = 19.5 uM | Inhibition of human recombinant CYP3A4 by fluorescence assay | ChEMBL. | 26643218 |
IC50 (ADMET) | = 55.9 uM | Inhibition of human recombinant CYP2C19 by fluorescence assay | ChEMBL. | 26643218 |
MIC (functional) | = 0.21 ug ml-1 | Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 after 5 days by microdilution method | ChEMBL. | 26643218 |
Vdss (ADMET) | Volume of distribution at steady state in mouse | ChEMBL. | 26643218 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.